Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP715761.RAAJkLHKlQqjyNT4qOGeXUQlB06KvmI9_2z6ZK6QdRcfc130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715761.RAAJkLHKlQqjyNT4qOGeXUQlB06KvmI9_2z6ZK6QdRcfc130_provenance.
• NP307957.RAjvbQI_SxgOjsJuNjoEZD6dv9m79NSQXSBBWy9GAbU_Q130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307957.RAjvbQI_SxgOjsJuNjoEZD6dv9m79NSQXSBBWy9GAbU_Q130_provenance.
• NP397259.RAxU0yK8ah39ZXqtkhoZIeGrA9rXkvObu_rUjMkD4XxAI130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397259.RAxU0yK8ah39ZXqtkhoZIeGrA9rXkvObu_rUjMkD4XxAI130_provenance.
• assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP878836.RAXn4i_yewHY7yFjD6vYt-Nn_i4NIHiDcL3KlkasX65Zw130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878836.RAXn4i_yewHY7yFjD6vYt-Nn_i4NIHiDcL3KlkasX65Zw130_provenance.
• NP916240.RAQnEa0ZfUBe8TlKKxf2rB_ZnULJc1JacjqlaoF4bm4XY130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916240.RAQnEa0ZfUBe8TlKKxf2rB_ZnULJc1JacjqlaoF4bm4XY130_provenance.
• NP342781.RA1yobjoV8_egOD_uTtinkZ-noXBc6xShbqzv8qCHb9Pw130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342781.RA1yobjoV8_egOD_uTtinkZ-noXBc6xShbqzv8qCHb9Pw130_provenance.
• NP342783.RA9poVFdVJbFoxPE3LSK5dbtHUlWh1XqkqOfE8UtjmWQA130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342783.RA9poVFdVJbFoxPE3LSK5dbtHUlWh1XqkqOfE8UtjmWQA130_provenance.
• NP342786.RA08hsh32eTxAZbPV-EwtS4aa0DRGR7GXbxG7UTyDqK38130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342786.RA08hsh32eTxAZbPV-EwtS4aa0DRGR7GXbxG7UTyDqK38130_provenance.
• NP390402.RAH40vgGpaJhenSfhesLByLybp5GnMHvAKzd9_kU5f8Nw130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390402.RAH40vgGpaJhenSfhesLByLybp5GnMHvAKzd9_kU5f8Nw130_provenance.
• NP342784.RAY3tsQICn4_uRvJ8UU8CmhJU4nMxxaynZDAsGk-TFcpU130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342784.RAY3tsQICn4_uRvJ8UU8CmhJU4nMxxaynZDAsGk-TFcpU130_provenance.
• NP342785.RAXJymzct1XA9hT9XiHUdhf4dCSDiuFHMICzrwj9hfOHU130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342785.RAXJymzct1XA9hT9XiHUdhf4dCSDiuFHMICzrwj9hfOHU130_provenance.
• NP342787.RAZ98lTlhrsU4qrZ-iTNLjBL73hacIFACmv1_rES5C9jg130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342787.RAZ98lTlhrsU4qrZ-iTNLjBL73hacIFACmv1_rES5C9jg130_provenance.
• assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP872697.RAh1-lp6f1UsJGkx3eorxWvb10quuJ859TowmqkYZWcKg130_assertion description "[PAR-2-mediated intestinal electrolyte secretion by release of mast cell tryptase and potentiation of PAR-2 expression by tumor necrosis factor-alpha may contribute to the hypersecretion observed in inflammatory processes such as chronic inflammatory bowel disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872697.RAh1-lp6f1UsJGkx3eorxWvb10quuJ859TowmqkYZWcKg130_provenance.